TP53 and neoplasm: Similarly, an HR of 3.359 for ARID1A negative tumors versus ARID1A positive tumors, an HR of 3.408 for p53 aberrant expression versus p53 regulated expression and an HR of 2.251 for ß-Catenin weak/negative membranous and positive nuclear expression versus ß-Catenin positive membranous expression meant a 3.359, 3.408 respectively 2.251 fold increased risk for tumor-related death for patients who belonged to the first subgroups.